The Direct Healthcare Expenditures of Prostate Cancer by Disease Severity: Evidence from US National Survey Data
# Background In the United States, approximately 2.8 million men have a history of prostate cancer (PC). # Objective This study quantified the effects of PC, overall and by disease severity on direct healthcare costs to insurers and patients. # Methods Using 1996–2010 data from the Medical Expendi...
Saved in:
| Main Authors: | Peter J. Mallow, Jie Chen, John A. Rizzo, John R. Penrod, Geralyn C. Trudel, Teresa M. Zyczynski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2016-10-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/9844 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000–2021
by: Harshith Thyagaturu, et al.
Published: (2024-10-01) -
Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
by: Keith L. Davis, et al.
Published: (2015-01-01) -
Health insurance type, healthcare utilization and out-of-pocket expenditure in the face of COVID-19: Evidence from Thai national survey data.
by: Chantal Herberholz, et al.
Published: (2025-01-01) -
The complexity of pharmaceutical expenditures across U.S. states
by: Lisa Cross, et al.
Published: (2025-05-01) -
Directorates of the us of defense expenditures of the AUKUS alliance
by: Ya.S. Hryshchenko
Published: (2024-04-01)